These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23787290)

  • 21. 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists.
    Haydar SN; Yun H; Andrae PM; Mattes J; Zhang J; Kramer A; Smith DL; Huselton C; Graf R; Aschmies S; Schechter LE; Comery TA; Robichaud AJ
    J Med Chem; 2010 Mar; 53(6):2521-7. PubMed ID: 20170099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and SAR of 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines as potent serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Kysil VM; Mitkin OD; Tkachenko SE; Okun I
    Bioorg Med Chem; 2011 Feb; 19(4):1482-91. PubMed ID: 21277782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclopropyl-tryptamine analogues: synthesis and biological evaluation as 5-HT(6) receptor ligands.
    Szalata C; Szymoniak J; Fabis F; Butt-Gueulle S; Rault S; Bertus P; Gérard S; Sapi J
    ChemMedChem; 2013 Jan; 8(1):70-3. PubMed ID: 23129513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT₂B and 5-HT₇ receptor antagonists. Part 2.
    Moritomo A; Yamada H; Watanabe T; Itahana H; Koga Y; Akuzawa S; Okada M
    Bioorg Med Chem; 2014 Aug; 22(15):4323-37. PubMed ID: 24916029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel tetrahydropyrido[3,2-c]pyrroles as 5-HT(7) antagonists.
    Rudolph DA; Dvorak CA; Dvorak L; Nepomuceno D; Bonaventure P; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2011 Jan; 21(1):42-4. PubMed ID: 21159507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
    Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
    Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solution phase parallel synthesis of substituted 3-phenylsulfonyl-[1,2,3]triazolo[1,5-a]quinazolines: selective serotonin 5-HT(6) receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Kovalenko SM; Mitkin OD; Okun IM; Ravnyeyko IM; Tkachenko SE; Zaremba OV
    J Comb Chem; 2010 Jul; 12(4):445-52. PubMed ID: 20349953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel quinazolinone derivatives as 5-HT7 receptor ligands.
    Na YH; Hong SH; Lee JH; Park WK; Baek DJ; Koh HY; Cho YS; Choo H; Pae AN
    Bioorg Med Chem; 2008 Mar; 16(5):2570-8. PubMed ID: 18083580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Thia-4,7-diaza-spiro[4.4]nonane-3,6-dione: a structural motif for 5-hydroxytryptamine 6 receptor antagonism.
    Hostetler G; Dunn D; McKenna BA; Kopec K; Chatterjee S
    Chem Biol Drug Des; 2014 Feb; 83(2):149-53. PubMed ID: 24119217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonists of 5-HT₆ receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationship.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Kysil VM; Mitkin OD; Vorobiev AA; Okun I
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4273-80. PubMed ID: 22664127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT₇ receptor antagonists.
    Zajdel P; Kurczab R; Grychowska K; Satała G; Pawłowski M; Bojarski AJ
    Eur J Med Chem; 2012 Oct; 56():348-60. PubMed ID: 22926225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.
    van Loevezijn A; Venhorst J; Iwema Bakker WI; de Korte CG; de Looff W; Verhoog S; van Wees JW; van Hoeve M; van de Woestijne RP; van der Neut MA; Borst AJ; van Dongen MJ; de Bruin NM; Keizer HG; Kruse CG
    J Med Chem; 2011 Oct; 54(20):7030-54. PubMed ID: 21866910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 6-Sulfonylbenzothiazolones as potential scaffolds for the design of 5-HT6 ligands.
    Larchanche PE; Ultré V; Le Broc D; Ballandone C; Furman C; Dallemagne P; Melnyk P; Carato P
    Eur J Med Chem; 2015 Mar; 92():807-17. PubMed ID: 25637882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and Structure-Activity Relationship Analysis of 5-HT₇ Receptor Antagonists: Piperazin-1-yl Substituted Unfused Heterobiaryls.
    Strekowski L; Sączewski J; Raux EA; Fernando NT; Klenc J; Paranjpe S; Raszkiewicz A; Blake AL; Ehalt AJ; Barnes S; Baranowski TC; Sullivan SM; Satała G; Bojarski AJ
    Molecules; 2016 Mar; 21(4):433. PubMed ID: 27043518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists.
    Tsai Y; Dukat M; Slassi A; MacLean N; Demchyshyn L; Savage JE; Roth BL; Hufesein S; Lee M; Glennon RA
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2295-9. PubMed ID: 11055342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of cycloalkane-annelated 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines and their evaluation as 5-HT6 receptor antagonists.
    Ivachtchenko AV; Dmitriev DE; Golovina ES; Dubrovskaya ES; Kadieva MG; Koryakova AG; Kysil VM; Mitkin OD; Tkachenko SE; Okun IM; Vorobiov AA
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2133-6. PubMed ID: 20207539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT(6) receptor antagonists.
    Nirogi RV; Daulatabad AV; Parandhama G; Mohammad S; Sastri KR; Shinde AK; Dubey PK
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4440-3. PubMed ID: 20594839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.